Sean Maduck, See Remarks at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $77.91 ($3.2M) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Scheduled sale ($3.2M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.91 | 5,752 | $448K | 14.2% |
| 2 | $77.91 | 5,752 | $448K | 14.2% |
| 3 | $78.87 | 6,191 | $488K | 15.4% |
| 4 | $78.87 | 6,191 | $488K | 15.4% |
| 5 | $79.89 | 6,246 | $499K | 15.8% |
| 6 | $79.89 | 6,246 |
| $499K |
| 15.8% |
| 7 | $80.77 | 1,811 | $146K | 4.6% |
| 8 | $80.77 | 1,811 | $146K | 4.6% |
| Total | $79.08 avg | 40,000 | $3.2M | 100% |
| Filing → |
| CORT | SELL | 2026-08-18 | $419K | — | Filing → |
| CORT | SELL | 2026-08-12 | $118K | — | Filing → |
| CORT | SELL | 2026-08-05 | $2.3M | — | Filing → |